WuXi Biologics (Cayman) Inc
WuXi Biologics (Cayman)'s GHG Emissions Data Preview
In 2023, WuXi Biologics (Cayman) completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
WuXi Biologics (Cayman) has also provided a category-level breakdown for 6 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into WuXi Biologics (Cayman)'s Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of WuXi Biologics (Cayman) amounted to 181,916 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of WuXi Biologics (Cayman) increased by 7.12%, suggesting that the company faced challenges in reducing its emissions from its core operations.
WuXi Biologics (Cayman)'s Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are WuXi Biologics (Cayman)'s Scope 1 emissions?
In 2023, the total Scope 1 emissions of WuXi Biologics (Cayman) were 32,687 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has WuXi Biologics (Cayman) reduced its Scope 1 emissions over time?
Since 2019, WuXi Biologics (Cayman)'s Scope 1 emissions have increased by 208.83%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), WuXi Biologics (Cayman)'s Scope 1 emissions decreased by 3.18%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are WuXi Biologics (Cayman)'s Scope 2 emissions?
In 2023, WuXi Biologics (Cayman) reported Scope 2 greenhouse gas (GHG) emissions of 149,229 tCOâ‚‚e using the location-based method.
Has WuXi Biologics (Cayman) reduced its Scope 2 emissions over time?
Compared to the previous year (2022), WuXi Biologics (Cayman)'s Scope 2 emissions (Location-Based) have remained relatively stable, indicating that WuXi Biologics (Cayman) 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does WuXi Biologics (Cayman) use for Scope 2 reporting?
In 2023, WuXi Biologics (Cayman) reported its Scope 2 emissions using the location-based method.
WuXi Biologics (Cayman)'s Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 (Unspecified Calculation Method)
Insights into WuXi Biologics (Cayman)'s Value Chain Emissions
In 2023, WuXi Biologics (Cayman) reported 65,463.77 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of WuXi Biologics (Cayman) includes a breakdown across 6 of the 15 Scope 3 categories defined by the GHG Protocol, up from 4 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain
WuXi Biologics (Cayman)'s Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are WuXi Biologics (Cayman)'s Scope 3 emissions?
In 2023, WuXi Biologics (Cayman) reported total Scope 3 emissions of 65,463.77 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.
Compared to the previous year (2022), WuXi Biologics (Cayman)'s Scope 3 emissions increased by 142.95%, suggesting that the company faced challenges in reducing emissions across its value chain.
What categories of Scope 3 emissions does WuXi Biologics (Cayman) disclose?
In 2023, WuXi Biologics (Cayman) reported emissions for 6 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of WuXi Biologics (Cayman)'s Scope 3 emissions?
In 2023, the largest contributors to WuXi Biologics (Cayman)'s Scope 3 emissions were:
- Fuel- and Energy-Related Services (Cat. 3): 35,385.14 tCOâ‚‚e (54.05%)
- Employee Commuting (Cat. 7): 19,654.27 tCOâ‚‚e (30.02%)
- Waste Generated in Operations (Cat. 5): 5,040.1 tCOâ‚‚e (7.7%)
WuXi Biologics (Cayman)'s Scope 3 Emissions by Categories
Insights into WuXi Biologics (Cayman)'s Total Carbon Footprint
In 2023, WuXi Biologics (Cayman) reported a total carbon footprint of 247,379.77 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 25.72% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to WuXi Biologics (Cayman)'s total carbon footprint was Scope 2 emissions, accounting for 60.32% of the company's total carbon footprint, followed by Scope 3 emissions at 26.46%.